850.06
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $850.06, with a volume of 797.05K.
It is up +1.09% in the last 24 hours and up +11.34% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$840.90
Open:
$841.87
24h Volume:
797.05K
Relative Volume:
0.72
Market Cap:
$99.52B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
22.10
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
+2.24%
1M Performance:
+11.34%
6M Performance:
+1.90%
1Y Performance:
+19.42%
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MCK
Mckesson Corp
|
850.06 | 98.45B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
311.15 | 60.29B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
229.35 | 53.41B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
84.61 | 9.74B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.46 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
McKesson Corporation (MCK) Stock Forecasts - Yahoo Finance
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
The McKesson WoundCare Essentials KitMcKesson Corp. bets on practical home treatment - AD HOC NEWS
McKesson Corporation (MCK) Announces Results of Annual Shareholders Meeting - GuruFocus
MCK|Mckesson Corp|Price:840.900|Chg%:+16.780 - TradingKey
Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK) - Yahoo Finance
LLY6081912 Bond Profile — Key Metrics - TradingView
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
RH Picks McKesson Exec As New Legal And Compliance Chief - Law360
Mckesson Corp (MCK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MCK|Mckesson Corp|Price:835.005|Chg%:+10.515 - TradingKey
Form 4 McKesson For: 24 July By Investing.com - Investing.com Canada
Mckesson Corp (MCK) Institutional Confidence - TradingKey
LLY3699591 Bond Profile — Key Metrics - TradingView
McKesson Director Kathleen Wilson-Thompson Receives 277 Shares via 2022 Stock Plan Grant on July 22, 2026 - Kalkine Media
McKesson Director Lynne Doughtie Awarded 277 Restricted Stock Units in 2026 Board Compensation - Kalkine Media
McKesson Director James H. Hinton Awarded 277 Restricted Stock Units Under 2022 Equity Plan - Kalkine Media
MCKB Bond Profile — Key Metrics - TradingView
LLY6082063 Bond Profile — Key Metrics - TradingView
MCKESSON CORP : CITIGROUP RAISES TARGET PRICE TO $1000 FROM $945 - Bitget
US581557BT1 Bond Profile — Key Metrics - TradingView
A19WCE Bond Profile — Key Metrics - TradingView
Here's Why McKesson (MCK) Fell More Than Broader Market - Yahoo Finance
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share - Finviz
Is Trending Stock McKesson Corporation (MCK) a Buy Now? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in McKesson a Decade Ago - Yahoo Finance
McKesson raises quarterly dividend 15% to $0.94 per share By Investing.com - Investing.com Canada
McKesson raises quarterly dividend 15% to $0.94 per share - Investing.com
Mckesson Corporation (MCK) News, Articles, Events & Latest Updates - Stocktwits
McKesson Marks 10th Straight Year of Dividend Growth With $0.94 Payout - Stock Titan
McKesson (MCK) Declines More Than Market: Some Information for Investors - Yahoo Finance
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
MCKC Bond Profile — Key Metrics - TradingView
US581557BY0 Bond Profile — Key Metrics - TradingView
McKesson's Q1 2027 Earnings: What to Expect - Barchart.com
LLY5600584 Bond Profile — Key Metrics - TradingView
A Look at McKesson Corp (MCK) After 5.7% Gain -- GF Value $794.8 - GuruFocus
LLY5237191 Bond Profile — Key Metrics - TradingView
Jonathan Jackson from Illinois’s 1st district makes trades in Hilton, McKesson, and Sphere Entertainment stocks - Investing.com
Here’s Why McKesson Corporation (MCK) Slid in Q2 - Yahoo Finance
McKesson: Embedding Impact and Purpose Across Operations - Healthcare Digital
XS156717452 Bond Profile — Key Metrics - TradingView
LLY6082068 Bond Profile — Key Metrics - TradingView
McKesson (MCK) Stock Dips While Market Gains: Key Facts - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
US581557BC8 Bond Profile — Key Metrics - TradingView
McKesson stock holds steady as healthcare distribution scale anchors long-term appeal - Ad-hoc-news.de
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
McKesson Stock (MCK) Opinions on Political Stock Purchases - Quiver Quantitative
US581557BX2 Bond Profile — Key Metrics - TradingView
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):